Screener
Candel Therapeutics, Inc. CADL Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Candel Therapeutics, Inc.’s 10-Q, filed August 13, 2026. Open the filing →
- Filed
- Aug 13, 2026, 8:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-347980
FAQ
- What is Candel Therapeutics, Inc.'s net income?
- Candel Therapeutics, Inc. (CADL) reported net income of -$38.91M in Q2 2026.
- How has Candel Therapeutics, Inc.'s net income changed year-over-year?
- Candel Therapeutics, Inc.'s net income decreased by 711.2% year-over-year, from -$4.8M to -$38.91M.
- What is the long-term trend for Candel Therapeutics, Inc.'s net income?
- Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s net income has grown at a 0.3% compound annual growth rate (CAGR), from -$37.72M to -$38.18M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Candel Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude